• Article metrics
  • Last updated: Fri, 10 Oct 2025 11:02:56 Z

First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

Access & Citations

  • 5572
    Article Accesses
  • 51
    Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

Online attention

Altmetric score 38
  • 40 tweeters
  • 2 Facebook pages
  • 2 news outlets
  • 1 Redditors
  • 23 Mendeley

This article is in the 94th percentile (ranked 22,008th) of the 377,016 tracked articles of a similar age in all journals and the 43rd percentile (ranked 86th) of the 152 tracked articles of a similar age in Nature Medicine

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.

Mentions in news and blogs

This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.